JO
KERX

John Overdeck’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

John Overdeck’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-23,295
Closed -$397K – 2458
2014
Q1 		$397K Sell
23,295
-9,347
-29% -$141K ﹤0.01% 1567
2013
Q4 		$423K Buy
32,642
+8,683
+36% +$104K ﹤0.01% 1737
2013
Q3 		$242K Buy
23,959
+1,377
+6% +$12.3K ﹤0.01% 1571
2013
Q2 		$169K Buy
+22,582
New +$176K ﹤0.01% 1811

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

John Overdeck's KERX Position: Q2 2014 in Review

John Overdeck sold out of Keryx Biopharmaceuticals Inc (KERX) in Q2 2014, closing a stake of 23,295 shares — an estimated $397K sold.

John Overdeck first reported a position in KERX in Q2 2013 and held it in 4 quarters. The position peaked at $423K in Q4 2013. 135 funds tracked by Wall St. Rank hold KERX as of Q2 2014.

  • John Overdeck reported no remaining Keryx Biopharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • John Overdeck sold 23,295 Keryx Biopharmaceuticals Inc shares in Q2 2014, an estimated $397K.
  • John Overdeck first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • John Overdeck's Keryx Biopharmaceuticals Inc position peaked at $423K in Q4 2013.
  • 135 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q2 2014.

Based on Two Sigma Investments's 13F filing for Q2 2014, filed 14 Aug 2014.